Related Experiment Videos
Tumour-associated surface antigen(s) in human astrocytomas
Oncology
|January 1, 1975
Summary
Researchers identified a new surface antigen, human astrocytoma-associated antigen (HAAA), common to human astrocytomas. This discovery aids in distinguishing astrocytomas from other tumors and tissues.
Area of Science:
- Neuro-oncology
- Immunology
- Biochemistry
Background:
- Astrocytomas are a type of primary brain tumor.
- Identifying specific tumor markers is crucial for diagnosis and treatment.
- Surface antigens can serve as potential targets for immunotherapies.
Purpose of the Study:
- To identify and characterize surface antigens specific to human astrocytomas.
- To develop a method for distinguishing astrocytomas from other human tumors and tissues.
Main Methods:
- Generation of hetero-antiserum against cultured human astrocytoma cells.
- Assay of antibody activity using dye exclusion cytotoxicity testing.
- Absorption experiments to confirm antigen specificity.
Main Results:
- A common surface antigen, designated human astrocytoma-associated antigen (HAAA), was identified in seven human astrocytomas.
- HAAA was detected in six additional astrocytoma cultures.
- HAAA was not found in other tested human tumors and tissues, indicating specificity.
Conclusions:
- HAAA is a promising tumor-associated antigen for human astrocytomas.
- The presence of HAAA in vivo was confirmed through absorption studies.
- HAAA may have diagnostic and therapeutic implications for astrocytoma patients.